Results:
We enrolled 945 patients, of whom 354 (37.5%) were admitted to hospital. Of 74 (7.8%) patients with a subsequent serious adverse event, 36 (49%) had not been admitted after the initial emergency visit. Multivariable modelling identified 5 variables that were independently associated with adverse events: prior intubation, initial heart rate ≥ 110/ minute, being too ill to do a walk test, hemoglobin < 100 g/L and urea ≥ 12 mmol/L. A preliminary risk scale incorporating these and 5 other clinical variables produced risk categories ranging from 2.2% for a score of 0 to 91.4% for a score of 10. Using a risk score of 2 or higher as a threshold for admission would capture all patients with a predicted risk of adverse events of 7.2% or higher, while only slightly increasing admission rates, from 37.5% to 43.2%.
serious adverse events. Once validated, this information should help in efforts to improve and standardize admission practices for patients with COPD seeen in the emergency department, diminishing both unnecessary admissions and unsafe discharge decisions.
Methods

Design and setting
We conducted a prospective observational cohort study in 6 Canadian teaching hospitals in Ottawa, Ontario (2 sites); Toronto, Ont.; Kingston, Ont.; Montréal, Quebec; and Edmonton, Alberta. The combined annual emergency department volume for these hospitals was about 350 000 patient visits. 6 
Study population
We included a convenience sample of adults 50 years of age or older who presented during weekday hours to the emergency department because of symptoms of acute shortness of breath secondary to exacerbation of COPD. Exacerbation of COPD was defined as an increase in at least 2 of 3 specified symptoms (breathlessness, sputum volume, sputum purulence) requiring an urgent visit to the emergency department for additional treatment. 2 For all included patients, COPD had been diagnosed previously or was diagnosed during the index emergency department visit on the basis of 1-year history of chronic dyspnea or cough with sputum production. Patients must have had a history of 15 pack-years or more of cigarette smoking and prior or current evidence of moderate airflow obstruction. 5 We excluded patients who were obviously too ill to be considered for discharge or who were other wise unsuitable for the study because of resting oxygen saturation < 85%; heart rate ≥ 130/minute; systolic blood pressure < 85 mm Hg; confusion, disorientation or severe dementia; ischemic chest pain requiring treatment on arrival; acute ST elevation by electrocardiog raphy on arrival; death from chronic illness expected within weeks; arrival from a nursing home or chronic care facility; or enrolment in the study within previous 2 months.
The research ethics boards of all 6 hospitals provided approval for this study. The research ethics boards of 3 of the hospitals specified that patients' written informed consent was required, whereas those at the other 3 sites waived the need for written consent.
Data collection
The patients were assessed by trained registered respiratory therapists or registered nurses. The target assessment period was 4 to 8 hours after in itial treatment, but patients could be considered for enrolment from 2 to 15 hours after treatment. A central study nurse coordinator regularly evaluated the quality of the patient assessments.
We selected the variables to be assessed in the study on the basis of our clinical experience and Temperature, °C, mean ± SD 36.6 ± 0.9
Heart rate, per minute, mean ± SD 93.0 ± 19.5
Respiratory rate, per minute, mean ± SD 23.6 ± 5.9
Systolic blood pressure, mm Hg, mean ± SD 140.9 ± 25.6
SaO2 by oximetry, † %, mean ± SD 93.3 ± 5.5
Duration of respiratory distress, h, mean ± SD 87.0 ± 114.4
Canadian Triage Acuity Scale score, ‡ median (IQR) reports in the literature. 2, [7] [8] [9] We collected data from each patient's history, general examination, laboratory tests and a standardized 3-minute walk test, during which the patient walked at his or her own pace for 3 minutes, regardless of distance. [10] [11] [12] [13] Patients could use their normal walking aids but could not be supported by another person. During this test, patients used no supplementary oxygen or used their usual home oxygen flow level. The same model of recording pulse oximeter (Criticare 504DXP) was used at all sites to record heart rate and oxygen saturation levels.
Outcome measures
The primary outcome was a serious adverse event, defined as either death from any cause within 30 days of the index emergency department visit or any of the following events within 14 days of the index emergency department visit, regardless of whether the patient was initially admitted: admission to a monitored unit, excluding monitoring by telemetry; endotracheal intubation or need for noninvasive ventilation after hospital admission, unless already receiving noninvasive ventilation at home; myocardial infarction, as defined by international consensus standards; 14 major procedure (coronary artery bypass graft, percutaneous coronary intervention, other cardiac surgery or new hemodialysis); or, for patients who were discharged after the initial visit, return to the emergency department for any related medical problem within 14 days followed by admission to hospital (return to the emergency department without associated admission was not considered an adverse event). We used hospital records and provincial death records to assess the primary outcome measure, with blinding as to patient status for the predictor variables.
Data analyses
We used appropriate univariable analyses to assess associations between the primary outcome (a serious adverse event) and clinical variables. We categorized continuous variables using the most discriminative cut points. We conducted logistic regression with stepwise selection for those variables found to be associated with serious adverse events on univariable analysis (p < 0.05), as well as for clinically sensible interaction terms. We conducted the analyses by visit rather than by individual patient. Using accepted approaches, we created a risk scale by rounding up the lowest logistic regression β coefficient to 1, which then served as the lowest common denominator for assigning point values to the score items. 15 We assessed the classification performance of the risk score by internal validation using the bootstrap method, 16 ,17 whereby we drew 1000 resamples with replacement from the original sample. We applied the COPD risk scale and calculated the classification performance measures (sensitivity, specificity, positive likelihood ratio and negative likelihood ratio) for each of the 1000 replicate samples. We evaluated the optimism of the bootstrap samples by comparing the averages of performance measures taken over 1000 replicates and the performance measures calculated in the original sample.
Results
Study sample
Of 1993 patient visits between September 2007 and April 2010, 945 met the inclusion criteria and were included in the analysis ( Table 1 ). The other 1048 visits were excluded primarily because Note: IQR = interquartile range, SaO2 = arterial saturation of oxygen, SD = standard deviation. *Except where indicated otherwise. †Arterial saturation of oxygen by oximetry was measured on room air for ambulatory patients and on oxygen for patients who arrived by ambulance. ‡Canadian Triage Acuity Scale ranges from 1 (most urgent) to 5 (least urgent).
Research
the patients presented when research staff were not available. The characteristics of excluded patient visits were similar (Appendix 1, available at www.cmaj .ca/lookup /suppl /doi:10.1503 /cmaj .130968 /-/DC1). Among the enrolled patients, there were 74 (7.8%) serious adverse events. Of concern, 36 (49%) of these occurred in the 591 patients who were not admitted at the time of the initial visit (Table 2 ). In addition, 2 (22%) of the 9 deaths occurred within 30 days among patients initially discharged home from the emergency department. Tables 3 and 4 show the association between a serious adverse event and variables from the history, physical examination and laboratory investigations. Some continuous variables were further categorized using cut points ( Table 5 ).
Univariable and multivariable data analyses
The multivariable logistic regression model was developed from a reduced dataset of the 844 cases (89.3%) without missing values ( Table 6 ). The Hosmer-Lemeshow χ 2 goodness-of-fit statistic was nonsignificant (p = 0.7), which indicated a good fit to the data. The area under the receiver operating characteristic curve was 0.80 (95% confidence interval 0.74-0.85), meaning that the model correctly classified serious adverse events for 80% of cases. Variables that were not significant in the final model included age, walk test performance, disposition status (admitted or discharged) and several interaction terms. We conducted a secondary analysis using multiple imputation with 50 samples, and the resultant model had the same 10 variables, with only minor changes to the scores of 2 variables (Appendices 2 and 3, available at www.cmaj.ca /lookup/suppl/doi:10.1503/cmaj.130968/-/DC1).
Preliminary risk scale
The preliminary COPD risk scale (Tables 7 and 8) consisted of 10 elements from the history (coronary bypass graft, intervention for peripheral vascu- Note: CTAS = Canadian Triage Acuity Scale, ECG = electrocardiogram, NT-proBNP = N-terminal B-type natriuretic peptide, pCO2 and pO2 = partial pressure of carbon dioxide and oxygen, SaO2 = arterial oxygen saturation, SD = standard deviation. *Where data were not available for all patients in both groups, n values for both groups are shown parenthetically. †Except where indicated otherwise. lar disease, intubation for respiratory distress), examination (heart rate on arrival ≥ 110/min, posttreatment oxygen saturation < 90% or heart rate ≥ 120/min) and investigations (acute ischemic changes on electrocardiography, pulmonary congestion on chest radiography, hemoglobin < 100 g/L, urea ≥ 12 mmol/L, serum carbon dioxide ≥ 35 mmol/L). The risk scale had a maximum score of 16. We found that the risk of a serious adverse event ranged from 2.2%, for a score of 0, to 91.4%, for a total score of 10. There was good calibration between observed and expected proba- bilities of a serious adverse event up to a score of 6 (Figure 1 ), beyond which there was variability because of small numbers. We compared the classification performance and expected admission proportions for the Ottawa COPD Risk Scale with current practice (as reflected by current study data) at the 6 study hospitals ( Table 9 ). Use of the scale could improve upon the sensitivity of current practice, which had only 51% (38/74) of patients who subsequently experienced a serious adverse event being admitted on the first emergency department visit. For example, choosing total point scores of 1, 2 or 3 as the threshold for admission would be associated with sensitivities for a serious adverse event of 91.2%, 80.9% or 60.3%, respectively. These theoretical admission thresholds would result in admission rates of 57.6%, 43.2% or 20.0%, respectively, as compared with the observed admission rate of 37.5% at the study sites.
The classification performance of the final score categories was validated using the sensitivity, specificity, positive likelihood ratio and negative likelihood ratio. This internal validation showed the risk scores to be highly accurate across 1000 replications with the bootstrap method (Appendix 4, available at www.cmaj.ca /lookup /suppl/doi:10.1503/cmaj.130968/-/DC1).
16
Interpretation
Among patients who presented to the emergency department with acute exacerbation of COPD, we found a relatively high frequency of serious adverse events, a modest hospital admission rate and a concerning proportion of poor outcomes among patients initially discharged home. We found that some 20 clinical and laboratory predictors were strongly associated with the development of serious adverse events. Multivariable analyses resulted in a concise and accurate model involving 10 unique, independent, highrisk factors, 4 from the initial clinical assessment, 5 from bedside investigations and 1 from reassessment after emergency department treatment. These high-risk factors are readily available and do not require sophisticated imaging or expensive testing to assist decision-making, yet have not been explicitly presented in previous models. These factors could assist physicians in identifying patients most at risk for adverse outcomes and most in need of hospital admission. The 10-element preliminary COPD risk scale provides a quantitative estimate of the risk of poor outcomes. We expect that this risk scale, once fully validated, will be widely used to improve both hospital admission practices and the safety of management decisions in the emergency department. [18] [19] [20] We are concerned by the number of serious adverse events among patients with COPD who were discharged from the emergency department. Identification of high-risk characteristics by physicians has the potential to substantially improve patient safety by helping to ensure that patients who are most at risk for poor outcomes are admitted. Although Canadian hospitals would struggle to admit 80% of patients with COPD, as we understnad is currently done in US hospitals, we believe that even a modest increase in admission rates (e.g., to 50% from the current Research 8 CMAJ 37.5%) would very likely lead to safer management practices. More important than increasing the admission percentage is ensuring admission of the correct patients, i.e., those at greatest risk of a poor outcome. Alternatively, the scale could be used to identify at-risk patients who should have guaranteed early follow-up, perhaps in specialized COPD clinics.
There have been no large, robust evaluations of risk factors to assist with admission decisions for patients with COPD in the emergency department. Previous prospective studies conducted in the emergency department had one or more of these limitations: small sample size, no inclusion of response to therapy, no functional testing such as a walk test and no prospective validation. 7, [21] [22] [23] [24] A larger study (in France) was limited by no evaluation of response to therapy and lack of follow-up mortality data. 25 Other prospective studies conducted only after admission to hospital have been limited by similar concerns, and most of these attempted only to predict mortality. [26] [27] [28] [29] [30] Others involved retrospective analyses of existing databases, were focused on inpatients or mortality, and were not directly applicable to the emergency department. [31] [32] [33] [34] [35] Strengths and limitations Our study had several strengths, including multi centre and rigorous prospective collection of real-time clinical data, comprehensive followup and unique use of the 3-minute walk test. Nonetheless, some aspects of the study warrant discussion. First, the study included both admitted and discharged patients, which we believe is the correct methodologic approach. Admission status may confound the likelihood of a serious adverse event, since it is possible that some admitted patients will not experience an adverse event because they receive more intensive therapy in hospital. Conversely, those same patients might have experienced an adverse event if they had been discharged home. Our objectives, however, were to identify high-risk characteristics and develop a preliminary risk scale that ensures appropriate admission of high-risk patients (i.e., sensitivity) while minimizing the admission of low-risk patients (i.e., specificity). We could do this only by evaluating admitted patients. We also note that admitted status was not significantly associated with serious adverse events in the multivariable model.
We chose not to evaluate spirometry findings in the emergency department, because this modality is often unavailable and was thought to be of limited usefulness for predicting short-term outcomes. We believe that use of the "monitored unit" (not telemetry) as a criterion for a serious adverse event is an important outcome that almost always reflects severity of illness. Patients treated in a monitored unit would likely have experienced substantial morbidity if they had been discharged, because they were bedridden and required constant cardiac monitoring. This preliminary risk scale should be prospectively validated in a new set of emergency department patients with COPD. Although we had few outcomes relative to the number of predictors, inter- nal validation with bootstrapping showed that the estimate and classification performance for risk scores were stable. 36 We chose not to adjust the analysis, despite the fact that some patients were enrolled more than once. We were unable to enrol a large number of eligible patients who presented outside of normal business hours, but we detected no selection bias. Some readers may be surprised that 4 cardiovascular variables were associated with serious adverse events in patients with a res- Note: COPD = chronic obstructive pulmonary disease. *For each COPD Risk Scale score, the value shown is the estimated hospital admission rate if threshold were greater than or equal to the specified point total (e.g., if threshold were set to point total ≥ 2, 43.2% of the patients would have been admitted). †Model was developed using data from the 844 patients who had no missing values. ‡Threshold values ≥ 4 were deemed not clinically reasonable because of poor sensitivity.
piratory condition, but cardiovascular disease and COPD are well known as common comorbidities that lead to worse outcomes than either condition alone. 3, 5, 25, 37 In addition, we know that some exacerbations of COPD are accom panied by simultaneous exacerbation of heart failure. Finally, it is possible, although unlikely, that some return emergency department visits were not identified among patients who returned to a different hospital. If such events did occur, we believe that they would not have had a significant effect on the results.
Conclusion
Patients with exacerbation of COPD are commonly admitted to hospital, but many such patients are discharged home from the emergency department and then experience serious adverse events or death. We have identified high-risk characteristics and developed a unique risk scale that can be used to stratify the risk of poor outcomes for patients with COPD seen in the emergency department and to enable rational and safe disposition decisions. Once validated, this scale will ultimately benefit both patients and health care systems by ensuring appropriate admissions, targeting those who need early follow-up and diminishing unnecessary hospital admissions.
